{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:36:52Z","timestamp":1767890212343,"version":"3.49.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T00:00:00Z","timestamp":1531699200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011725","name":"Meningitis Now","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01621","type":"journal-article","created":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T08:02:56Z","timestamp":1531728176000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Cross-Reactive Bactericidal Antimeningococcal Antibodies Can Be Isolated From Convalescing Invasive Meningococcal Disease Patients Using Reverse Vaccinology 2.0"],"prefix":"10.3389","volume":"9","author":[{"given":"Fadil A.","family":"Bidmos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Nadel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin R.","family":"Screaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Simon","family":"Kroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Langford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.meegid.2008.04.002","article-title":"Genetics and evolution of Neisseria meningitidis: importance for the epidemiology of meningococcal disease","volume":"8","author":"Caugant","year":"2008","journal-title":"Infect Genet Evol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(06)68609-1","article-title":"Clinical recognition of meningococcal disease in children and adolescents","volume":"367","author":"Thompson","year":"2006","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMra052116","article-title":"Community-acquired bacterial meningitis in adults","volume":"354","author":"van de Beek","year":"2006","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/14760584.2017.1258308","article-title":"The global meningococcal initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection","volume":"16","author":"Borrow","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"B5","doi-asserted-by":"publisher","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","article-title":"Global epidemiology of meningococcal disease","volume":"27","author":"Harrison","year":"2009","journal-title":"Vaccine"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/INF.0b013e3181ef25f7","article-title":"Long-term sequelae of childhood bacterial meningitis: an underappreciated problem","volume":"30","author":"Chandran","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/S0022-3476(81)80250-8","article-title":"Complications and sequelae of meningococcal infections in children","volume":"99","author":"Edwards","year":"1981","journal-title":"J Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1097\/00006454-199611000-00009","article-title":"Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience","volume":"15","author":"Kirsch","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/cid\/cis892","article-title":"Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity","volume":"56","author":"Kristiansen","year":"2012","journal-title":"Clin Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1080\/21645515.2018.1458175","article-title":"Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines","volume":"14","author":"Villena","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"B12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jinf.2016.07.016","article-title":"Clinical diagnoses and outcomes of 4619 hospitalised cases of laboratory-confirmed invasive meningococcal disease in England: linkage analysis of multiple national databases","volume":"73","author":"Edge","year":"2016","journal-title":"J Infect"},{"key":"B13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis: implications for vaccine development and pathogenesis","volume":"322","author":"Finne","year":"1983","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","article-title":"The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens","volume":"30","author":"Serruto","year":"2012","journal-title":"Vaccine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1016\/S0140-6736(16)31921-3","article-title":"Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study","volume":"388","author":"Parikh","year":"2016","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e19513","DOI":"10.1371\/journal.pone.0019513","article-title":"Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso","volume":"6","author":"Delrieu","year":"2011","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0187466","DOI":"10.1371\/journal.pone.0187466","article-title":"Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign","volume":"12","author":"Soeters","year":"2017","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/S1473-3099(16)30253-5","article-title":"Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data","volume":"16","author":"Sidikou","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S1473-3099(17)30301-8","article-title":"Impact of MenAfriVac in nine countries of the African meningitis belt, 2010\u201315: an analysis of surveillance data","volume":"17","author":"Trotter","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1099\/jmm.0.46288-0","article-title":"Epidemiology of meningococcal disease in England and Wales 1993\/94 to 2003\/04: contribution and experiences of the Meningococcal Reference Unit","volume":"55","author":"Gray","year":"2006","journal-title":"J Med Microbiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"B26","DOI":"10.1016\/j.vaccine.2011.12.032","article-title":"The changing and dynamic epidemiology of meningococcal disease","volume":"30","author":"Halperin","year":"2012","journal-title":"Vaccine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1016\/j.vaccine.2017.03.007","article-title":"The epidemiology of invasive meningococcal disease in EU\/EEA countries, 2004\u20132014","volume":"35","author":"Whittaker","year":"2017","journal-title":"Vaccine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0158315","DOI":"10.1371\/journal.pone.0158315","article-title":"Temporal changes in BEXSERO\u00ae antigen sequence type associated with genetic lineages of Neisseria meningitidis over a 15-year period in Western Australia","volume":"11","author":"Mowlaboccus","year":"2016","journal-title":"PLoS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/nbt.2492","article-title":"High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire","volume":"31","author":"DeKosky","year":"2013","journal-title":"Nat Biotechnol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/nbt.2782","article-title":"The promise and challenge of high-throughput sequencing of the antibody repertoire","volume":"32","author":"Georgiou","year":"2014","journal-title":"Nat Biotechnol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1084\/jem.20151960","article-title":"Reverse vaccinology 2.0: human immunology instructs vaccine antigen design","volume":"213","author":"Rappuoli","year":"2016","journal-title":"J Exp Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1743-422X-7-28","article-title":"Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient","volume":"7","author":"Schieffelin","year":"2010","journal-title":"Virol J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nature06890","article-title":"Rapid cloning of high-affinity human monoclonal antibodies against influenza virus","volume":"453","author":"Wrammert","year":"2008","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fimmu.2012.00078","article-title":"Origin and function of circulating plasmablasts during acute viral infections","volume":"3","author":"Fink","year":"2012","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nprot.2009.3","article-title":"Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen","volume":"4","author":"Smith","year":"2009","journal-title":"Nat Protoc"},{"key":"B32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1101\/pdb.prot093757","article-title":"Direct and indirect cell-based enzyme-linked immunosorbent assay","volume":"2017","author":"Kohl","year":"2017","journal-title":"Cold Spring Harb Protoc"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0133855","DOI":"10.1371\/journal.pone.0133855","article-title":"Investigation into the antigenic properties and contributions to growth in blood of the meningococcal haemoglobin receptors, HpuAB and HmbR","volume":"10","author":"Bidmos","year":"2015","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1128\/CDLI.12.8.970-976.2005","article-title":"Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup B, strain 44\/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine","volume":"12","author":"Borrow","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0022-1759(85)90337-0","article-title":"Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation","volume":"78","author":"Woodward","year":"1985","journal-title":"J Immunol Methods"},{"key":"B36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.immuni.2018.01.005","article-title":"Infants infected with respiratory syncytial virus generate potent neutralizing antibodies that lack somatic hypermutation","volume":"48","author":"Goodwin","year":"2018","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1128\/JVI.06075-11","article-title":"Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans","volume":"86","author":"Wrammert","year":"2012","journal-title":"J Virol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/jac\/dku047","article-title":"Induction of human plasmablasts during infection with antibiotic-resistant nosocomial bacteria","volume":"69","author":"Band","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.15252\/emmm.201606330","article-title":"Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis","volume":"8","author":"Zimmermann","year":"2016","journal-title":"EMBO Mol Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.4049\/jimmunol.1701253","article-title":"Isolation and characterization of antigen-specific plasmablasts using a novel flow cytometry-based Ig capture assay","volume":"199","author":"Pinder","year":"2017","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01621\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T08:03:01Z","timestamp":1531728181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01621\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,16]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2018.01621"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01621","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,16]]},"article-number":"1621"}}